We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A qualitative study on the lived experiences of individuals with end-stage kidney disease (ESKD) accessing haemodialysis in Northern Ghana.
- Authors
Boateng, Edward Appiah; Iddrisu, Aduni Amina; Kyei-Dompim, Joana; Amooba, Philemon Adoliwine
- Abstract
Background: Haemodialysis is Ghana's most common form of renal replacement therapy for end-stage kidney disease (ESKD). However, limited research has explored the experiences of individuals with ESKD receiving haemodialysis in relatively poorer regions, especially in the northern part of the country. This study explored individuals' experiences with accessing haemodialysis in northern Ghana and was guided by Levesque's conceptual framework of access to healthcare. Methods: The study utilized a phenomenological design, and participants were recruited through the purposive sampling method. Individuals with ESKD receiving haemodialysis for at least three months were interviewed using a semi-structured interview guide. Trustworthiness was ensured through credibility, transferability, dependability, and confirmability. Results: Most of the participants had a history of hypertension that progressed to ESKD due to poor management practices – mainly purchasing antihypertensive drugs over the counter without visits to the hypertensive clinic contributed greatly to the delay in diagnosing ESKD in northern Ghana. The geographical location of the dialysis centre and limited dialysis machines were the key barriers to adequate access to dialysis. Many participants had two dialysis sessions per week instead of thrice a week. Some were even having one session per week due to the distance from their residence to the dialysis centre and the costs involved. Conclusion: Access to haemodialysis for individuals with ESKD in the northern part of the country is relatively limited in many ways compared with that in the southern part of the country. Health policies should include funding for haemodialysis and a collaboration with pharmaceutical companies to consider manufacturing dialysis concentrates to reduce the cost. Additionally, there should be deliberate efforts to design and implement programs to promote ESKD awareness in the country, especially in relatively poorer regions.
- Subjects
GHANA; CHRONIC kidney failure; HEMODIALYSIS; RENAL replacement therapy; HEMODIALYSIS facilities; NONPRESCRIPTION drugs; ARTERIOVENOUS fistula; HYPERTENSIVE crisis
- Publication
BMC Nephrology, 2024, Vol 25, Issue 1, p1
- ISSN
1471-2369
- Publication type
Article
- DOI
10.1186/s12882-024-03622-x